Omega Healthcare Investors INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Lisa Egbuonu-Davis, a Director of Omega Healthcare Investors Inc, reported a transaction in 5,131 shares of common stock on August 7, 2026.
NYSE
Omega Healthcare Investors reports on Chief Financial Officer Robert O. Stephenson's acquisition of Profits Interest Units and Operating Partnership Units.
NYSE
C. Taylor Pickett, CEO of Omega Healthcare Investors, reports changes in beneficial ownership of company securities, including vested Profits Interest Units and OP Units.
NYSE
Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors Inc., reported the vesting of Profits Interest Units into Operating Partnership Units on June 30, 2026.
NYSE
Vikas Gupta, Chief Investment Officer at Omega Healthcare Investors, reports on the vesting of Profits Interest Units into Operating Partnership Units.
NYSE
Matthew P. Gourmand of Omega Healthcare Investors reports on the vesting of Profits Interest Units into Operating Partnership Units, impacting beneficial ownership.
NYSE
Neal Ballew, Chief Accounting Officer at Omega Healthcare Investors Inc., reported transactions involving common stock purchases and sales related to employee stock plans and tax withholding.
NYSE
Omega Healthcare Investors, Inc. reports a restricted stock grant to Director Burke W. Whitman as part of compensation.
NYSE
Director Stephen D. Plavin reports on the vesting of Profits Interest Units and the grant of new units in Omega Healthcare Investors.
NYSE
Omega Healthcare Investors, Inc. reports a restricted stock grant to Director Kevin J. Jacobs as part of his compensation.
NYSE
Omega Healthcare Investors, Inc. director Barbara B. Hill reported transactions involving Profits Interest Units and Operating Partnership Units.
NYSE
Lisa Egbuonu-Davis, a Director at Omega Healthcare Investors Inc., was granted restricted stock valued at $43.67 per share.
NYSE
Omega Healthcare Investors Director Anand Kapila reports receipt of 6,205 deferred stock units as part of his annual grant.
NYSE
Omega Healthcare Investors' Chief Investment Officer, Vikas Gupta, saw a significant portion of his performance-based equity awards vest into redeemable OP Units.
NYSE
Omega Healthcare Investors' CFO, Robert O. Stephenson, reported the vesting and conversion of performance-based equity units into common stock, effective March 31, 2026.
NYSE
Omega Healthcare Investors President Matthew Gourmand reported the vesting of performance-based equity units into OP Units, increasing his indirect beneficial ownership.
NYSE
Omega Healthcare Investors CEO C. Taylor Pickett's future vesting of performance-based equity units into OP Units on March 31, 2026, has been disclosed.
NYSE
Omega Healthcare Investors' Chief Accounting Officer, Neal Ballew, increased his beneficial ownership through ESPP purchases and derivative conversions.
NYSE
Omega Healthcare Investors' Chief Accounting Officer, Neal Ballew, was granted 14,401 Profits Interest Units vesting in 2028.
NYSE
Omega Healthcare Investors President Matthew Gourmand acquired 42,805 Profits Interest Units, vesting in 2028, as part of a pre-arranged plan.
NYSE
Omega Healthcare Investors' Chief Investment Officer, Vikas Gupta, acquired 18,898 Profits Interest Units, increasing his beneficial ownership.
NYSE
Omega Healthcare Investors' Chief Legal Officer, Gail D. Makode, was granted 11,407 Profits Interest Units, vesting in 2028.
NYSE
Omega Healthcare Investors CEO C. Taylor Pickett was granted 57,331 Profits Interest Units, vesting in 2028, as part of his compensation.
NYSE
Omega Healthcare Investors' Chief Financial Officer, Robert O. Stephenson, was granted 20,799 Profits Interest Units, which vest in 2028.
NYSE
Omega Healthcare Investors CFO Robert O. Stephenson was awarded 158,594 Profits Interest Units, contingent on performance and vesting through 2026.
NYSE
Omega Healthcare Investors CEO C. Taylor Pickett earned 381,610 performance-based Profits Interest Units, vesting quarterly in 2026.
NYSE
Omega Healthcare Investors' Chief Legal Officer, Gail D. Makode, was awarded 81,929 performance-based Profits Interest Units, vesting quarterly throughout 2026.
NYSE
Omega Healthcare Investors' Chief Investment Officer, Vikas Gupta, was awarded 81,929 Profits Interest Units based on 2023-2025 performance, vesting quarterly in 2026.
NYSE
Omega Healthcare Investors' President, Matthew Gourmand, was awarded 81,929 performance-based Profits Interest Units, vesting quarterly in 2026.
NYSE
Omega Healthcare Investors' Chief Accounting Officer, Neal Ballew, was awarded 81,929 Profits Interest Units, vesting quarterly throughout 2026.